The JAK/STAT pathway in obesity and diabetes

FEBS J. 2016 Aug;283(16):3002-15. doi: 10.1111/febs.13709. Epub 2016 Apr 1.

Abstract

Diabetes mellitus are complex, multi-organ metabolic pathologies characterized by hyperglycemia. Emerging evidence shows that the highly conserved and potent JAK/STAT signaling pathway is required for normal homeostasis, and, when dysregulated, contributes to the development of obesity and diabetes. In this review, we analyze the role of JAK/STAT activation in the brain, liver, muscle, fat and pancreas, and how this affects the course of the disease. We also consider the therapeutic implications of targeting the JAK/STAT pathway in treatment of obesity and diabetes.

Keywords: JAK/STAT signaling pathway; adipose tissue; brain; cytokines; diabetes; hormones; liver; muscle; obesity; pancreas.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adipose Tissue / enzymology
  • Adipose Tissue / metabolism
  • Animals
  • Brain / enzymology
  • Brain / metabolism
  • Diabetes Mellitus / enzymology
  • Diabetes Mellitus / metabolism*
  • Diabetes Mellitus / therapy
  • Fatty Liver / metabolism
  • Humans
  • Insulin-Secreting Cells / enzymology
  • Insulin-Secreting Cells / metabolism
  • Janus Kinases / antagonists & inhibitors
  • Janus Kinases / metabolism*
  • Mice
  • Muscle, Skeletal / enzymology
  • Muscle, Skeletal / metabolism
  • Obesity / enzymology
  • Obesity / metabolism*
  • Obesity / therapy
  • STAT Transcription Factors / antagonists & inhibitors
  • STAT Transcription Factors / metabolism*
  • Signal Transduction

Substances

  • STAT Transcription Factors
  • Janus Kinases